COMMUNIQUÉS West-GlobeNewswire

-
Innate Pharma : Upcoming investor conferences
07/01/2019 -
Innate Pharma : Prochains rendez-vous investisseurs
07/01/2019 -
Xenon Pharmaceuticals Outlines 2019 Key Milestones
07/01/2019 -
Adverum Biotechnologies Provides 2019 Outlook
07/01/2019 -
Oxford Immunotec Announces Board Approval of $100 Million Share Repurchase Program and Reaffirms Growth Expectations for Fourth Quarter 2018
07/01/2019 -
Galapagos initiates NOVESA Phase 2a trial in patients with systemic sclerosis
06/01/2019 -
Adamas Provides Preliminary Fourth Quarter and Full-Year 2018 GOCOVRI™ Sales Results and Outlines Key Priorities for 2019
06/01/2019 -
Gritstone Oncology Announces Updated Presentation Time at the 37th Annual J.P. Morgan Healthcare Conference
06/01/2019 -
Executive Women In Bio Releases First Annual Directory of Boardroom Ready Executive Profiles
05/01/2019 -
CORRECTING and REPLACING -- Unum Therapeutics Announces 2019 Goals and Expected Milestones
05/01/2019 -
ChemioCare Initiates Development Program in Pediatric CINV
04/01/2019 -
Arvinas Receives Authorization to Proceed for its IND Application for PROTAC™ Therapy to Treat Patients with Metastatic Castration-Resistant Prostate Cancer
04/01/2019 -
Poseida Therapeutics Appoints Two Independent Directors, Adding Leaders for Compensation and Governance Functions
04/01/2019 -
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/01/2019 -
Amarin Provides Preliminary 2018 Results and 2019 Outlook
04/01/2019 -
Atara Biotherapeutics to Participate in the 37th Annual J.P. Morgan Healthcare Conference
04/01/2019 -
Fibrocor and Galapagos sign partnership in fibrosis
04/01/2019 -
Candel Therapeutics Completes $28.7 Million Series B Financing
04/01/2019 -
Stryker to host conference call on January 29, 2019
04/01/2019
Pages